At the last internal audit, a regulatory affairs professional identified a need for a corrective action for the manufacturing process. Which of the following stakeholders should be notified FIRST?

Which of the following is MOST appropriate for the purpose of lot release of biologics?

Following the introduction of a new regulation, an evaluation of the company's products by the regulatory affairs professional indicates that 60 percent do not comply with the regulation.
What should the regulatory affairs professional do FIRST to meet the new requirement?

Which of the following BEST describes the purpose of the ICH?

In order to develop a global drug product, what is the MOST important environmental characteristic to consider in the country of intended use?